| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
TriSalus Life Sciences, Inc.
13D/A
TLSI · 89680M101
|
14.0% |
8/4/2025
Event 7/31/2025
|
||||
| Frankenius Equity AB | 14.0% | |||||
| Paul Frankenius | 14.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.